Department of Dermatology, the Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei Province, P.R. China.
Int J Dermatol. 2022 Feb;61(2):252-256. doi: 10.1111/ijd.15892. Epub 2021 Sep 14.
Bullous pemphigoid (BP) patients were vulnerable to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection because they have similar risk factors, so we should pay attention to patients with BP during the epidemic of coronavirus disease-19 (COVID-19). As far as treatment is concerned, many strategies for BP were changed during the epidemic. Plasmapheresis not only has been included in the guidelines for BP but also has been used successfully to rescue COVID-19 patients, especially in severe cases. Therefore, it is a feasible choice for BP patients, especially for refractory BP patients, infected with SARS-CoV-2. Apart from these, we have reviewed some points for attention during the plasmapheresis session.
大疱性类天疱疮（BP）患者由于具有相似的危险因素而易感染严重急性呼吸综合征冠状病毒 2（SARS-CoV-2），因此在冠状病毒病 19（COVID-19）流行期间，我们应关注 BP 患者。就治疗而言，在流行期间，许多 BP 治疗策略发生了变化。血浆置换不仅被纳入 BP 指南，而且成功地用于抢救 COVID-19 患者，尤其是重症患者。因此，对于感染 SARS-CoV-2 的 BP 患者，尤其是难治性 BP 患者来说，这是一种可行的选择。除此之外，我们还回顾了血浆置换过程中需要注意的一些要点。
